Featured News

LUPUS FEATURES

Revolutionizing Lupus Care with Advanced Predictive Blood Testing

Revolutionizing Lupus Care with Advanced Predictive Blood Testing

AMPEL BioSolutions introduces LuGENE®, a cutting-edge blood test poised to revolutionize the management of systematic lupus erythematosus (SLE). LuGENE® leverages predictive artificial intelligence (AI) to detect genetic biomarkers indicative of inflammation-driven SLE flares, offering clinicians valuable insights for tailored treatment strategies.

read more
LuGENE® Lupus Test Launches to Predict Flares & Drug Targets

LuGENE® Lupus Test Launches to Predict Flares & Drug Targets

AMPEL BioSolutions announces a breakthrough in personalized precision medicine that will revolutionize the way doctors manage the autoimmune disease Lupus.  Revealed in the peer-reviewed journal Genome Medicine and being made available to patients through a US follow-on study, the LuGENE® blood test forecasts patient flares and drug targets from gene expression utilizing predictive AI.

read more

LUPUS NEWS

Doctors and patients monitor Lupus with mobile app

Doctors and patients monitor Lupus with mobile app

CLICK TO VIEW ORIGINAL ARTICLE > by Josh Mandell   A Charlottesville company is helping to lead a global scientific effort to better understand and treat lupus, an autoimmune disease sometimes called “the cruel mystery.” AMPEL Bio Solutions, a biomedical...

read more
Trial of LuPRO mobile app predicts Lupus flares

Trial of LuPRO mobile app predicts Lupus flares

CLICK TO VIEW ORIGINAL ARTICLE > BY KATIE O'CONNOR, Richmond Times-Dispatch In 50 years, only one treatment was approved by the U.S. Food and Drug Administration to treat lupus, an autoimmune disease in which a person’s immune system attacks their healthy organs...

read more
Digital Dialogue: Lupus Awareness Month

Digital Dialogue: Lupus Awareness Month

For Lupus Awareness Month in May, NBC12 hosted a Digital Dialogue Tuesday night featuring advocates and specialists in the Lupus field, treatment, coping with the disease, finding a cure and new advancements being pioneered right here in Virginia.

read more
Data mining could lead to therapy advances

Data mining could lead to therapy advances

Peter E. Lipsky, MD, Co-Founder and Chief Executive Officer of AMPEL BioSolutions, Charlottesville, VA, works to change that, and he will discuss his efforts during the Clinical Science symposium Mining Big Data for Drug Repurposing.

read more

Pin It on Pinterest